from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0709/rpmC

LFCtreatmentdescriptionclass of inhibitor

-0.939

Amikacinug/mL Amikacintranslation

-1.704

Cap5-10ug/mL Capreomycintranslation

-1.832

Rox10-50 ug/mL Roxithromycintranslation

0.105

SM2-5 ug/mL Streptomycintranslation

-1.739

Tet5-10 ug/mL Tetracyclinetranslation

-1.158

Rif0.2-5ug/mL Rifampicintranscription

-0.197

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.804

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.094

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.238

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.001

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.206

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.317

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.194

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.423

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.198

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.735

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.903

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.940

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.256

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.798

KCN5-20 ug/mL Potassium cyaniderespiration

-1.029

NaN30.2-2 mM Sodium aziderespiration

1.012

Nigericin50 uM Nigericinrespiration

-0.806

TRC10-150 ug/mL Triclosanrespiration

0.246

TRZ10-25 ug/mL Thioridazinerespiration

0.962

Valinomycin0.5-10 uM Valinomycinrespiration

0.761

ZnSO42 mM ZnSO4respiration

-0.402

menadione6-10 ug/mL Menadionerespiration

-0.380

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.699

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.477

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.021

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.635

NRP_1Non-replicating persistence stage 1dosRassociated

0.902

Amp0.2mg/mL AmpicillincellWall

0.904

Cephalexin20-100 ug/mL CephalexincellWall

0.579

Cerulenin0.32-5 ug/mL CerulenincellWall

0.982

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.368

EMB10-20 ug/mL EthambutolcellWall

0.597

Eta12-40 ug/mL EthionamidecellWall

1.308

INH0.2-0.4 ug/mL IsoniazidcellWall

0.573

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.745

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.824

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.747

BZA0.12 mg/mL BenzamidearomaticAmides

-0.040

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.189

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.592

H2O24 mM hydrogen peroxideDNAdamaging

0.525

Levo10 ug/mL LevofloxacinDNAdamaging

1.028

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.101

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.552

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.722

UVUV-irradiationDNAdamaging

0.130

ARP41-4 ug/mL Antitubercular compound ARP4?

0.485

Antimycin12.5-50 ug/mL Antimycin A?

1.041

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.141

PA_110-50 ug/mL Antitubercular compound PA-1?

0.217

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.004

PA8240.2-2 ug/mL PA-824?

-1.385

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.310

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.999

Verapamil50 uM Verapamil?

0.981

mercaptoethanol2 mM 2-Mercaptoethanol?

1.139

methoxatin10-20 ug/mL Methoxatin?